thyroid eye disease

SAN FRANCISCO and SUZHOU, China, May 18, 2026 Innovent Biologics presented new clinical and preclinical data from its next-generation...

WALTHAM, Mass., United States – May 5, 2026 Viridian Therapeutics Inc. has announced positive topline results from its Phase...

Thousand Oaks, California, USA, April 6, 2026 Phase 3 Success Expands TEPEZZA Treatment Options In a major advancement for...